Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-16Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-16A Randomized Double-Blind Phase IIA Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-15Functional Ovarian Reserve in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-14An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of Pociredir in Participants With Sickle Cell Disease (SCD) Who Have Participated in a Pociredir Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-14Managed Access Programs for SEG101, Crizanlizumab
-
CLINICAL_TRIALS study record update · 2026-04-13A Feasibility Study of Alendronate as Treatment for Osteonecrosis in Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2 Randomized Double-blind, Placebo-controlled Clinical Trial of Intravenous Citrulline for Vaso-occlusive Pain Episode in Hospitalized Patients With Sickle Cell Disease (CONQUER SCD Pain Trial)
-
CLINICAL_TRIALS study record update · 2026-04-13Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme: Prospective Multi-Centre Cohort Study
-
CLINICAL_TRIALS study record update · 2026-04-13A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Flexible-adaptive, Group Sequential Study to Evaluate the Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-09Kinetics of Pathogen Reduced Red Blood Cell Clearance in Subjects Undergoing Red Cell Exchange for Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-09Alternative Dosing And Prevention of Transfusions (ADAPT): A Prospective Study to Reduce Transfusion Requirements for Children With Sickle Cell Anemia Using Pharmacokinetics-based Hydroxyurea Dosing
-
CLINICAL_TRIALS study record update · 2026-04-09Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-08A Pilot Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-08Human Specimen Collection to Support Basic and Clinical Research
-
CLINICAL_TRIALS study record update · 2026-04-08Pre-Transplant Immune Suppression With Hematopoietic Cell Transplantation From Haploidentical Donors for Adults and Children With Sickle Cell Disease or ß-Thalassemia (Haplo PTCy)
-
CLINICAL_TRIALS study record update · 2026-04-08A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic
-
CLINICAL_TRIALS study record update · 2026-04-07An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
-
CLINICAL_TRIALS study record update · 2026-04-06Low-Dose Tocilizumab for Acute Chest Syndrome in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-06An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase 2, Open-label, Multicenter Study of Mitapivat in Subjects With Sickle Cell Disease and Nephropathy (RESIST)
-
CLINICAL_TRIALS study record update · 2026-04-02Exploring the Mediterranean Diet as A Promising Approach for Alleviating Chronic Pain in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-01Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-01Remote Self-Administered Acupressure for Pain Management in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-31Phase 1-2 Trial of Gamunex (Intravenous Gammaglobulin) for Sickle Cell Acute Pain